Eleanor Donegan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eleanor Donegan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Benicio Noronha Frey
McMaster University
3 shared publications Arela Agako
McMaster University
2 shared publicationsRandi E. McCabe
McMaster University; St. Joseph's Healthcare Hamilton
2 shared publications- Randi E. McCabe
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON L8S 4L8, Canada
2 shared publications - Sheryl M. Green
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
2 shared publications - Arela Agako
Department of Psychology, Neuroscience and Behaviour
1 shared publication
Latest Publications
- 1 July 2021
- Published by Elsevier in Behavior Therapy
- Vol. 52 (4) , 907-916
Cognitive Behavior Therapy for Women With Generalized Anxiety Disorder in the Perinatal Period: Impact on Problematic Behaviors
- 1 July 2021
- Published by Elsevier in Behavior Therapy
- Vol. 52 (4) , 907-916
Cognitive Behavior Therapy for Women With Generalized Anxiety Disorder in the Perinatal Period: Impact on Problematic Behaviors
- 20 January 2020
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 54 (4) , 423-432
Cognitive behavioral therapy for perinatal anxiety: A randomized controlled trial
Background: Up to one in five women meet diagnostic criteria for an anxiety disorder during the perinatal period (i.e. pregnancy and up to 1 year postpartum). While psychotropic medications are effective, they are associated with risks for mothers and babies. There is a growing demand for evidence-based non-pharmacological treatments for perinatal anxiety. Objective: To evaluate the effectiveness of a cognitive behavioral group therapy protocol for perinatal anxiety. Methods: In total, 96 women were randomized to cognitive behavioral group therapy or waitlist at a clinic specializing in women’s mental health. Participants were 22–41 years of age, pregnant or up to 6 months postpartum and had an anxiety disorder with or without comorbid depression. Results: Compared to waitlist, participants in cognitive behavioral group therapy reported significantly greater reductions in the primary outcome of anxiety (State-Trait Inventory of Cognitive and Somatic Anxiety, η 2 p = .19; Hamilton Anxiety Rating Scale, η 2 p = .16), as well as in secondary outcomes including worry (Penn State Worry Questionnaire, η 2 p = .29), perceived stress (Perceived Stress Scale, η 2 p = .33) and depressive symptoms (Edinburgh Postnatal Depression Scale, η 2 p = .27; Montgomery–Åsberg Depression Rating Scale, η 2 p = .11). Maternal status (pregnant, postpartum) and medication use were unrelated to treatment outcomes. All gains were maintained, or continued to improve, at 3-month follow-up. Conclusion: Cognitive behavioral group therapy was effective in improving anxiety and related symptoms among women with anxiety disorders in the perinatal period.
- 20 January 2020
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 54 (4) , 423-432
Cognitive behavioral therapy for perinatal anxiety: A randomized controlled trial
Background: Up to one in five women meet diagnostic criteria for an anxiety disorder during the perinatal period (i.e. pregnancy and up to 1 year postpartum). While psychotropic medications are effective, they are associated with risks for mothers and babies. There is a growing demand for evidence-based non-pharmacological treatments for perinatal anxiety. Objective: To evaluate the effectiveness of a cognitive behavioral group therapy protocol for perinatal anxiety. Methods: In total, 96 women were randomized to cognitive behavioral group therapy or waitlist at a clinic specializing in women’s mental health. Participants were 22–41 years of age, pregnant or up to 6 months postpartum and had an anxiety disorder with or without comorbid depression. Results: Compared to waitlist, participants in cognitive behavioral group therapy reported significantly greater reductions in the primary outcome of anxiety (State-Trait Inventory of Cognitive and Somatic Anxiety, η 2 p = .19; Hamilton Anxiety Rating Scale, η 2 p = .16), as well as in secondary outcomes including worry (Penn State Worry Questionnaire, η 2 p = .29), perceived stress (Perceived Stress Scale, η 2 p = .33) and depressive symptoms (Edinburgh Postnatal Depression Scale, η 2 p = .27; Montgomery–Åsberg Depression Rating Scale, η 2 p = .11). Maternal status (pregnant, postpartum) and medication use were unrelated to treatment outcomes. All gains were maintained, or continued to improve, at 3-month follow-up. Conclusion: Cognitive behavioral group therapy was effective in improving anxiety and related symptoms among women with anxiety disorders in the perinatal period.
- 26 October 2018
- Published by Taylor & Francis
- p. 26-35
Depression During Pregnancy and the Postpartum Period
The experience of sadness or depression during pregnancy or in the postpartum period can be an unsettling experience for new or expecting mothers. This experience, however, is relatively common, with up to 84% of women experiencing the ‘baby blues’ in the early postpartum period and 9–19% of women experiencing postpartum depression. Some women also experience depressive symptoms (e.g., sadness, loss of pleasure) during pregnancy. Chapter 2 provides an overview of these symptoms with the goal of helping women, their families, and their healthcare workers become more familiar with the nature and signs of depression in women during pregnancy and the postpartum. This chapter will help you distinguish between the ‘baby blues,’ clinical depression, and other mental health difficulties (e.g., postpartum psychosis), and to better understand the events or situations that can increase the risk of depression during pregnancy and the postpartum.
- 26 October 2018
- Published by Taylor & Francis
- p. 26-35
Depression During Pregnancy and the Postpartum Period
The experience of sadness or depression during pregnancy or in the postpartum period can be an unsettling experience for new or expecting mothers. This experience, however, is relatively common, with up to 84% of women experiencing the ‘baby blues’ in the early postpartum period and 9–19% of women experiencing postpartum depression. Some women also experience depressive symptoms (e.g., sadness, loss of pleasure) during pregnancy. Chapter 2 provides an overview of these symptoms with the goal of helping women, their families, and their healthcare workers become more familiar with the nature and signs of depression in women during pregnancy and the postpartum. This chapter will help you distinguish between the ‘baby blues,’ clinical depression, and other mental health difficulties (e.g., postpartum psychosis), and to better understand the events or situations that can increase the risk of depression during pregnancy and the postpartum.